Uncategorized

Peptide blends: what Wolverine, Glow and KLOW contain, and what nobody has tested

November 18, 2026  ·  6 min read  ·  How we write

The short version: A peptide blend is two or more separate research peptides freeze-dried into one vial. Wolverine is BPC-157 and TB-500, Glow adds GHK-Cu, and KLOW adds KPV on top of that. The label gives the combined amount rather than a per-peptide breakdown, which matters if you want to compare your work with published research. And the combinations themselves are close to unstudied: one 2026 rat study tested the Wolverine pair together, and nobody has tested Glow or KLOW as a mix.

View KLOW Blend & get a quote →

What a blend actually is

There’s nothing chemically new in a blend. Each peptide is still its own molecule; the blend simply puts them in one vial, freeze-dried together. Once water goes in, they share one solution.

Our three:

  • Wolverine: BPC-157 and TB-500.
  • Glow: BPC-157, TB-500 and GHK-Cu.
  • KLOW: BPC-157, TB-500, GHK-Cu and KPV.

The names are market nicknames. We found no published paper that uses them.

Why the split matters

Every paper on these peptides studies them one at a time and reports how much of that single compound was used. A vial could lean heavily towards one peptide or be split evenly, and the label would read the same.

Why you’d want it in your notes:

  • Comparison. You can only line your work up against the literature if you know how much of each compound you had.
  • Repeatability. A blend with a different ratio is, for research purposes, a different material.
  • Fixed proportions. In a blend you can’t change one peptide without changing the others. That’s worth knowing before you design anything around it.

We don’t print the split on the label. Message us with your batch number and we can confirm it.

See our lab reports before you order →

How to read a blend’s COA

A single-peptide COA usually covers identity, amount and purity. A blend puts several molecules in one sample, so look for these:

  • Every component named. Each peptide should appear on its own line, with its own measured result. A single figure for the whole vial can’t show you that one component came up short or went missing.
  • Metal content for copper peptides. GHK-Cu is a peptide holding copper, so a thorough report gives the peptide and the copper separately.
  • The batch number. It should match the vial in your hand.
  • A way to verify it. Independent labs such as Janoshik print a key you can check on their own site, so you know the report wasn’t edited.

Our guide to reading a COA goes through the general layout step by step.

What “not studied together” means

When we say a blend hasn’t been studied, we mean something specific. Each peptide has its own research record, some thin and some thicker. But nobody knows, from data, whether these compounds add up, cancel out or simply sit side by side once they share a vial.

There is now exactly one data point. In July 2026, a Turkish team published a rat study in Joint Diseases and Related Surgery. Thirty-two rats had their Achilles tendons cut and repaired, then got no peptide, BPC-157, TB-500 or both, for four weeks.

TB-500 on its own gave the clearest results, including tendons that took significantly more force to break than in the untreated rats. BPC-157 alone improved tissue scores, but not by a significant margin overall. The pair together improved one tissue score, but the authors reported that combining them gave no additional benefit over either peptide alone. They guessed the two might act on shared pathways further down the line, and said that idea still needs testing.

It’s one small study in rats. It’s still the only evidence on the Wolverine pairing, and it didn’t show the two doing more together. For Glow and KLOW, we found no study of the combination in any species.

Component In Evidence on its own US FDA safety note WADA 2026
BPC-157 Wolverine, Glow, KLOW A 2025 review found 36 studies, 35 of them preclinical Possible immune reaction for some routes; impurity concerns Prohibited (S0)
TB-500 Wolverine, Glow, KLOW Lab and animal work; FDA found no human exposure data Possible immune reaction from clumping; impurity concerns Prohibited (S2)
GHK-Cu Glow, KLOW Cell and animal work, plus skin cream studies in people Injectable use: possible immune reaction; limited human data Not named
KPV KLOW Early lab research; FDA found no human exposure data by any route Lacks important safety information Not named

All four sit on the FDA’s page of compounding substances that may present significant safety risks. Each nomination there now shows as withdrawn, with the risk notes still attached.

If you remember one thing: a blend is a convenience, not a finding. The only study of any of these pairings found no extra benefit from combining them, and the label total won’t tell you how much of each peptide you have.

Where the evidence stops

  • No human data on any blend. Not one trial of these combinations in people has been published or registered that we could find.
  • One animal study, for one pairing. The Wolverine pair has a single rat study. Glow and KLOW have none.
  • The parts are thin too. BPC-157’s human record is one small look-back report on knee pain. The FDA found no human exposure data at all for TB-500 or KPV. For GHK-Cu, the human evidence is skin creams.
  • Interactions are unknown. Sharing a solution could, in principle, affect how stable each peptide is. We found no published stability data for these mixtures.
  • Banned in sport. Two of the four parts are on WADA’s prohibited list, so every one of our blends contains at least one banned substance.

A note on framing

A blend saves a researcher from mixing several vials. That’s the whole of its advantage. It doesn’t carry any evidence that the parts work better together, and the single study on the question pointed the other way. We sell to researchers, and we’d rather you knew that before choosing a blend over the individual peptides.

Where JP fits

JP Research supplies Wolverine (10mg), Glow (70mg) and KLOW (80mg) as research-grade lyophilised powder, for laboratory research use only. The figure is the vial total. KLOW has an independent Janoshik report on its product page. We don’t hold reports for Wolverine or the 70mg Glow yet, and their product pages say so. If you’d rather work with single compounds, BPC-157, TB-500, GHK-Cu and KPV are all available on their own. Our reconstitution and storage guide covers handling.

Browse the recovery research range →

Sources

All JP Research products are supplied strictly for in-vitro research and laboratory use only. They are not intended for human or animal consumption, medical treatment, or diagnostic use. Nothing in this article constitutes medical advice.

Research access

Get restocks & our lab reports first

Restock alerts and the Certificates of Analysis we hold — straight to your phone. Research professionals only. No spam, leave anytime.

Chat to us